| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ATF5 IQGAP2 MYO5B MARK1 MARK3 IFT81 TTLL5 OBSCN PKD2L1 DAXX JAKMIP3 EPB41L4A IQGAP1 MYO5C KLHL5 STARD9 SVIL CEP135 ROCK1 MTCL1 CAMSAP1 MAP4K4 KIF17 MX2 | 5.64e-07 | 1099 | 139 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | histone H4K20 methyltransferase activity | 3.82e-05 | 10 | 139 | 3 | GO:0042799 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 7.12e-05 | 100 | 139 | 6 | GO:0030527 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 8.39e-05 | 103 | 139 | 6 | GO:0008276 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.37e-04 | 71 | 139 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | tubulin binding | ATF5 IFT81 TTLL5 JAKMIP3 STARD9 CEP135 MTCL1 CAMSAP1 MAP4K4 KIF17 MX2 | 2.07e-04 | 428 | 139 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | histone H4 methyltransferase activity | 2.09e-04 | 17 | 139 | 3 | GO:0140939 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.12e-04 | 230 | 139 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | histone H4K20me methyltransferase activity | 2.86e-04 | 4 | 139 | 2 | GO:0140941 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 4.61e-04 | 22 | 139 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | chromatin binding | REC8 MPO ASXL1 ATF5 H3-5 PHF19 NSD2 KMT5C ARX KMT5B SUV39H1 H3-3A MNT BAHCC1 | 6.55e-04 | 739 | 139 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | histone H4K20 monomethyltransferase activity | 7.09e-04 | 6 | 139 | 2 | GO:0140944 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.30e-03 | 68 | 139 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.37e-03 | 69 | 139 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.44e-03 | 308 | 139 | 8 | GO:0008017 | |
| GeneOntologyBiologicalProcess | cytokinesis | 9.67e-07 | 204 | 135 | 10 | GO:0000910 | |
| GeneOntologyBiologicalProcess | chromatin organization | ASXL1 SLF1 PHF19 NSD2 KMT5C CECR2 DAXX RNF40 RAD54L2 KMT2E H3-4 H3C15 KANSL2 BRD8 H3C1 KMT5B SUV39H1 H3-3A BAHCC1 | 6.09e-06 | 896 | 135 | 19 | GO:0006325 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 2.05e-05 | 127 | 135 | 7 | GO:0061640 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ASXL1 SLF1 PHF19 NSD2 KMT5C CECR2 DAXX RNF40 RAD54L2 KMT2E H3-4 H3C15 KANSL2 BRD8 H3C1 KMT5B SUV39H1 H3-3A BAHCC1 | 2.79e-05 | 999 | 135 | 19 | GO:0071824 |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 3.79e-05 | 95 | 135 | 6 | GO:0000281 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.80e-05 | 145 | 135 | 7 | GO:0051028 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 1.27e-04 | 3 | 135 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 1.27e-04 | 3 | 135 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 1.27e-04 | 3 | 135 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.56e-04 | 175 | 135 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.56e-04 | 175 | 135 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | cell cycle process | REC8 DRD2 ATF5 SLF1 INCENP IQGAP2 NEK10 CECR2 EXOC3 DAXX SYF2 KMT2E GEM IQGAP1 BNIP2 STARD9 SVIL CEP135 ASPM ROCK1 MTCL1 CSPP1 | 1.65e-04 | 1441 | 135 | 22 | GO:0022402 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.73e-04 | 178 | 135 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.20e-04 | 185 | 135 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 2.53e-04 | 4 | 135 | 2 | GO:2000689 | |
| GeneOntologyCellularComponent | nucleosome | 3.80e-06 | 138 | 138 | 8 | GO:0000786 | |
| GeneOntologyCellularComponent | condensed chromosome | REC8 SLF1 INCENP KMT5C NIFK KMT5B SUV39H1 H3-3A MTCL1 FAM9C NUP160 | 6.31e-06 | 307 | 138 | 11 | GO:0000793 |
| GeneOntologyCellularComponent | microtubule minus-end | 9.66e-06 | 7 | 138 | 3 | GO:0036449 | |
| GeneOntologyCellularComponent | chromosomal region | REC8 THOC7 SLF1 INCENP KMT5C DAXX H3-4 KMT5B SUV39H1 H3-3A MTCL1 NUP160 | 2.36e-05 | 421 | 138 | 12 | GO:0098687 |
| GeneOntologyCellularComponent | microtubule | INCENP IQGAP2 TTLL5 DAXX TTLL8 IQGAP1 SVIL ASPM MTCL1 CAMSAP1 KIF17 CSPP1 MX2 | 5.38e-05 | 533 | 138 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | chromosome, centromeric region | 9.30e-05 | 276 | 138 | 9 | GO:0000775 | |
| GeneOntologyCellularComponent | centriole | 1.48e-04 | 172 | 138 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.90e-04 | 254 | 138 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 3.00e-04 | 193 | 138 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 3.44e-04 | 91 | 138 | 5 | GO:0000794 | |
| GeneOntologyCellularComponent | microtubule organizing center | ATF5 SLF1 IFT81 TTLL5 ANKRD26 SFI1 KMT2E BNIP2 STARD9 CEP83 CEP135 ASPM ROCK1 CAMSAP1 KIF17 CSPP1 | 3.77e-04 | 919 | 138 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | midbody | 6.93e-04 | 222 | 138 | 7 | GO:0030496 | |
| GeneOntologyCellularComponent | chromatin | ATF5 H3-5 SLF1 INCENP NSD2 KMT5C CECR2 ARX DAXX RNF40 KMT2E H3-4 H3-7 H3C15 KANSL2 BRD8 H3C1 SUV39H1 H3-3A MNT | 1.72e-03 | 1480 | 138 | 20 | GO:0000785 |
| Domain | HISTONE_H3_1 | 8.21e-08 | 7 | 132 | 4 | PS00322 | |
| Domain | HISTONE_H3_2 | 1.63e-07 | 8 | 132 | 4 | PS00959 | |
| Domain | Histone_H3/CENP-A | 1.63e-07 | 8 | 132 | 4 | IPR000164 | |
| Domain | H3 | 1.63e-07 | 8 | 132 | 4 | SM00428 | |
| Domain | SET | 9.98e-06 | 41 | 132 | 5 | PF00856 | |
| Domain | IQ | 1.09e-05 | 71 | 132 | 6 | PF00612 | |
| Domain | SET | 1.78e-05 | 46 | 132 | 5 | SM00317 | |
| Domain | IQ | 2.34e-05 | 81 | 132 | 6 | SM00015 | |
| Domain | SET_dom | 2.68e-05 | 50 | 132 | 5 | IPR001214 | |
| Domain | SET | 2.68e-05 | 50 | 132 | 5 | PS50280 | |
| Domain | IQ_motif_EF-hand-BS | 4.26e-05 | 90 | 132 | 6 | IPR000048 | |
| Domain | SAM_MT43_SUVAR420_2 | 4.96e-05 | 2 | 132 | 2 | PS51570 | |
| Domain | Hist-Lys_N-MTase_Suvar4-20 | 4.96e-05 | 2 | 132 | 2 | IPR025790 | |
| Domain | IQ | 5.12e-05 | 93 | 132 | 6 | PS50096 | |
| Domain | RasGAP_C | 1.48e-04 | 3 | 132 | 2 | IPR000593 | |
| Domain | RasGAP_C | 1.48e-04 | 3 | 132 | 2 | PF03836 | |
| Domain | CH | 1.67e-04 | 73 | 132 | 5 | PS50021 | |
| Domain | CH-domain | 1.90e-04 | 75 | 132 | 5 | IPR001715 | |
| Domain | MARK/par1 | 2.95e-04 | 4 | 132 | 2 | IPR033624 | |
| Domain | Myosin-like_IQ_dom | 3.08e-04 | 19 | 132 | 3 | IPR027401 | |
| Domain | - | 3.08e-04 | 19 | 132 | 3 | 4.10.270.10 | |
| Domain | KA1 | 4.89e-04 | 5 | 132 | 2 | PF02149 | |
| Domain | Myosin_S1_N | 4.89e-04 | 5 | 132 | 2 | IPR008989 | |
| Domain | KA1_dom | 4.89e-04 | 5 | 132 | 2 | IPR001772 | |
| Domain | KA1 | 4.89e-04 | 5 | 132 | 2 | PS50032 | |
| Domain | - | 4.89e-04 | 5 | 132 | 2 | 3.30.310.80 | |
| Domain | Histone_H2A/H2B/H3 | 6.59e-04 | 56 | 132 | 4 | IPR007125 | |
| Domain | Histone | 6.59e-04 | 56 | 132 | 4 | PF00125 | |
| Domain | Dilute_dom | 7.30e-04 | 6 | 132 | 2 | IPR002710 | |
| Domain | DIL | 7.30e-04 | 6 | 132 | 2 | PF01843 | |
| Domain | DILUTE | 7.30e-04 | 6 | 132 | 2 | PS51126 | |
| Domain | DIL | 7.30e-04 | 6 | 132 | 2 | SM01132 | |
| Domain | CAMSAP_CH | 1.02e-03 | 7 | 132 | 2 | PF11971 | |
| Domain | KA1/Ssp2_C | 1.02e-03 | 7 | 132 | 2 | IPR028375 | |
| Domain | CAMSAP_CH | 1.02e-03 | 7 | 132 | 2 | IPR022613 | |
| Domain | CH | 1.16e-03 | 65 | 132 | 4 | SM00033 | |
| Domain | - | 1.44e-03 | 69 | 132 | 4 | 1.10.20.10 | |
| Domain | CH | 1.52e-03 | 70 | 132 | 4 | PF00307 | |
| Domain | - | 1.61e-03 | 71 | 132 | 4 | 1.10.418.10 | |
| Domain | PH_dom-spectrin-type | 1.73e-03 | 9 | 132 | 2 | IPR001605 | |
| Domain | BROMODOMAIN_1 | 2.25e-03 | 37 | 132 | 3 | PS00633 | |
| Domain | Bromodomain | 2.43e-03 | 38 | 132 | 3 | PF00439 | |
| Domain | Histone-fold | 2.85e-03 | 83 | 132 | 4 | IPR009072 | |
| Domain | BROMODOMAIN_2 | 3.02e-03 | 41 | 132 | 3 | PS50014 | |
| Domain | Bromodomain | 3.24e-03 | 42 | 132 | 3 | IPR001487 | |
| Domain | BROMO | 3.24e-03 | 42 | 132 | 3 | SM00297 | |
| Domain | - | 3.24e-03 | 42 | 132 | 3 | 1.20.920.10 | |
| Domain | Znf_PHD | 3.96e-03 | 91 | 132 | 4 | IPR001965 | |
| Domain | RasGAP | 4.27e-03 | 14 | 132 | 2 | SM00323 | |
| Domain | CNH | 4.27e-03 | 14 | 132 | 2 | SM00036 | |
| Domain | RasGAP_CS | 4.27e-03 | 14 | 132 | 2 | IPR023152 | |
| Domain | ZF_PHD_2 | 4.62e-03 | 95 | 132 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 4.80e-03 | 96 | 132 | 4 | PS01359 | |
| Domain | RasGAP | 4.90e-03 | 15 | 132 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.90e-03 | 15 | 132 | 2 | PS00509 | |
| Domain | START_lipid-bd_dom | 4.90e-03 | 15 | 132 | 2 | IPR002913 | |
| Domain | START | 4.90e-03 | 15 | 132 | 2 | PF01852 | |
| Domain | - | 4.90e-03 | 15 | 132 | 2 | 1.10.1000.11 | |
| Domain | CNH | 4.90e-03 | 15 | 132 | 2 | PF00780 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.90e-03 | 15 | 132 | 2 | PS50018 | |
| Domain | Sec7 | 4.90e-03 | 15 | 132 | 2 | PF01369 | |
| Domain | CNH | 4.90e-03 | 15 | 132 | 2 | PS50219 | |
| Domain | CNH_dom | 4.90e-03 | 15 | 132 | 2 | IPR001180 | |
| Domain | START | 4.90e-03 | 15 | 132 | 2 | PS50848 | |
| Domain | Sec7_alpha_orthog | 4.90e-03 | 15 | 132 | 2 | IPR023394 | |
| Domain | Post-SET_dom | 5.58e-03 | 16 | 132 | 2 | IPR003616 | |
| Domain | PostSET | 5.58e-03 | 16 | 132 | 2 | SM00508 | |
| Domain | SEC7 | 5.58e-03 | 16 | 132 | 2 | PS50190 | |
| Domain | Sec7 | 5.58e-03 | 16 | 132 | 2 | SM00222 | |
| Domain | - | 5.58e-03 | 16 | 132 | 2 | 1.10.506.10 | |
| Domain | Sec7_dom | 5.58e-03 | 16 | 132 | 2 | IPR000904 | |
| Domain | POST_SET | 5.58e-03 | 16 | 132 | 2 | PS50868 | |
| Domain | WW_DOMAIN_1 | 5.61e-03 | 51 | 132 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 5.61e-03 | 51 | 132 | 3 | PS50020 | |
| Domain | Pkinase | 5.73e-03 | 381 | 132 | 8 | PF00069 | |
| Domain | WW_dom | 5.92e-03 | 52 | 132 | 3 | IPR001202 | |
| Domain | A/G_cyclase_CS | 6.29e-03 | 17 | 132 | 2 | IPR018297 | |
| Domain | - | 6.66e-03 | 391 | 132 | 8 | 2.30.29.30 | |
| Domain | - | 7.04e-03 | 18 | 132 | 2 | 3.30.70.1230 | |
| Domain | RasGAP_dom | 7.04e-03 | 18 | 132 | 2 | IPR001936 | |
| Domain | Nucleotide_cyclase | 7.04e-03 | 18 | 132 | 2 | IPR029787 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGH_MMSET_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 4.16e-09 | 19 | 107 | 6 | M47442 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 5.77e-07 | 65 | 107 | 7 | M39374 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.47e-05 | 70 | 107 | 6 | M27231 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 1.71e-04 | 37 | 107 | 4 | M39756 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.24e-04 | 272 | 107 | 9 | M29619 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RHBDF1 IQGAP2 TMEM94 MARK3 MINK1 PSD3 ANKRD26 EXOC3 TBC1D22B ITGA3 H3C15 PTPN14 SH2D4A CLCN7 ROCK1 CAMSAP1 MAP4K4 PSD4 | 2.32e-11 | 569 | 142 | 18 | 30639242 |
| Pubmed | H3-5 IQGAP2 MYO5B NSD2 PPFIA2 IFT81 RGPD1 ANKRD26 FAM98A RAD54L2 H3-4 PNISR H3C15 UBLCP1 GSR IQGAP1 CCDC148 H3C1 STARD9 DGKK CEP83 ASPM H3-3A RPL7A BAHCC1 | 9.29e-10 | 1442 | 142 | 25 | 35575683 | |
| Pubmed | Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. | 2.04e-08 | 21 | 142 | 5 | 11242053 | |
| Pubmed | MARK1 TMEM94 MARK3 MINK1 PSD3 ANKRD26 EXOC3 ADGRL1 TBC1D22B LRCH1 PTPN14 ROCK1 MAP4K4 | 2.11e-08 | 421 | 142 | 13 | 36976175 | |
| Pubmed | Crystal structure of DPF3b in complex with an acetylated histone peptide. | 3.30e-08 | 9 | 142 | 4 | 27402533 | |
| Pubmed | TBKBP1 MARK1 MARK3 ANKRD26 TBC1D22B LRCH1 PTPN14 MTCL1 MAP4K4 CSPP1 THAP12 NUP160 WWC1 | 4.15e-08 | 446 | 142 | 13 | 24255178 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | MPO MAFG DHX16 ASXL1 EAPP INCENP RGPD1 EXOC3 SYF2 CWC22 IQGAP1 NIFK KANSL2 BRD8 SH2D4A SVIL CEP135 ASPM MTCL1 NUP160 | 5.46e-08 | 1155 | 142 | 20 | 20360068 |
| Pubmed | 8.60e-08 | 11 | 142 | 4 | 15471871 | ||
| Pubmed | Human PAD4 regulates histone arginine methylation levels via demethylimination. | 8.60e-08 | 11 | 142 | 4 | 15345777 | |
| Pubmed | DHX16 ASXL1 TMEM94 MARK3 PSD3 ADGRL1 DCAF5 ACOT11 STARD9 DZIP3 MTCL1 KIF17 | 1.24e-07 | 407 | 142 | 12 | 12693553 | |
| Pubmed | NDUFS7 EAPP MARK3 IFT81 TTLL5 MINK1 PSD3 ANKRD26 EXOC3 FAM98A DCAF5 RRP1 GSR NCBP3 NIFK PTPN14 H3C1 CLCN7 ASPM MAP4K4 CSPP1 RPL7A | 1.72e-07 | 1487 | 142 | 22 | 33957083 | |
| Pubmed | 2.58e-07 | 14 | 142 | 4 | 16267050 | ||
| Pubmed | Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection. | 2.66e-07 | 4 | 142 | 3 | 25275136 | |
| Pubmed | Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation. | 2.66e-07 | 4 | 142 | 3 | 16858404 | |
| Pubmed | PR-SET7 and SUV4-20H regulate H4 lysine-20 methylation at imprinting control regions in the mouse. | 2.66e-07 | 4 | 142 | 3 | 18724273 | |
| Pubmed | 3.51e-07 | 15 | 142 | 4 | 35907431 | ||
| Pubmed | INCENP NSD2 IFT81 TTLL5 ANKRD26 RRP1 BRD8 H3C1 CEP135 SLTM DZIP3 ROCK1 CAMSAP1 CSPP1 | 4.49e-07 | 645 | 142 | 14 | 25281560 | |
| Pubmed | 6.14e-07 | 74 | 142 | 6 | 36180920 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 16185088 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 7309716 | ||
| Pubmed | 1.20e-06 | 332 | 142 | 10 | 25693804 | ||
| Pubmed | Organismal differences in post-translational modifications in histones H3 and H4. | 1.32e-06 | 6 | 142 | 3 | 17194708 | |
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 10464286 | ||
| Pubmed | Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. | 1.32e-06 | 6 | 142 | 3 | 15525939 | |
| Pubmed | Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. | 1.32e-06 | 6 | 142 | 3 | 12560483 | |
| Pubmed | Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification. | 1.32e-06 | 6 | 142 | 3 | 17189264 | |
| Pubmed | TPTE MYO5B NSD2 MINK1 PSD3 WDR55 EXOC3 UBLCP1 NIFK PTPN14 SH2D4A CLCN7 SVIL CEP135 SLTM ROCK1 CSPP1 | 1.46e-06 | 1049 | 142 | 17 | 27880917 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H3-5 MARK3 RRP7BP DAXX H3-4 H3-7 H3C15 NKRF RRP1 IQGAP1 MYO5C NIFK H3C1 SVIL SLTM RPL7A | 1.83e-06 | 949 | 142 | 16 | 36574265 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H3-5 SLF1 INCENP RBM33 NSD2 FAM98A H3-4 CWC22 H3C15 NKRF NCBP3 NIFK BRD8 H3C1 SLTM H3-3A | 1.96e-06 | 954 | 142 | 16 | 36373674 |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 15684425 | ||
| Pubmed | Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. | 2.30e-06 | 7 | 142 | 3 | 11856369 | |
| Pubmed | HIRA and Daxx constitute two independent histone H3.3-containing predeposition complexes. | 2.30e-06 | 7 | 142 | 3 | 21047901 | |
| Pubmed | Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation. | 2.30e-06 | 7 | 142 | 3 | 24101509 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 20448663 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 15681610 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 16497732 | ||
| Pubmed | A Cul4 E3 ubiquitin ligase regulates histone hand-off during nucleosome assembly. | 3.68e-06 | 8 | 142 | 3 | 24209620 | |
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 28107649 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX16 THOC7 INCENP MYO5B MARK3 EVPL LRCH1 CWC22 NKRF RRP1 IQGAP1 NIFK PTPN14 H3C1 SVIL SLTM NUP160 RPL7A | 3.98e-06 | 1257 | 142 | 18 | 36526897 |
| Pubmed | 4.07e-06 | 102 | 142 | 6 | 9734811 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX16 MYO5B EXOC3 TFG H3C15 NKRF RRP1 IQGAP1 MYO5C NCBP3 NIFK SVIL SLTM MAP4K4 NUP160 RPL7A | 4.82e-06 | 1024 | 142 | 16 | 24711643 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | THOC7 TBKBP1 RBM33 ANKRD26 EXOC3 DAXX RNF40 RAD54L2 GSR PTPN14 ASPM ROCK1 | 5.78e-06 | 588 | 142 | 12 | 38580884 |
| Pubmed | Human tNASP promotes in vitro nucleosome assembly with histone H3.3. | 7.69e-06 | 31 | 142 | 4 | 25615412 | |
| Pubmed | PP1α, PP1β and Wip-1 regulate H4S47 phosphorylation and deposition of histone H3 variant H3.3. | 7.83e-06 | 10 | 142 | 3 | 23828041 | |
| Pubmed | NDUFS7 RHBDF1 RBM33 NSD2 MARK3 MINK1 WDR55 DAXX FAM98A PNISR H3C15 NKRF RRP1 IQGAP1 NIFK BRD8 H3C1 CEP83 THAP12 | 1.17e-05 | 1497 | 142 | 19 | 31527615 | |
| Pubmed | AKAP6 DENND2A NSD2 CECR2 RNF40 SFI1 LRCH1 CWC22 IQGAP1 MAP4K4 DAGLA | 1.21e-05 | 529 | 142 | 11 | 14621295 | |
| Pubmed | Identification of the BRD1 interaction network and its impact on mental disorder risk. | 1.26e-05 | 35 | 142 | 4 | 27142060 | |
| Pubmed | NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. | 1.66e-05 | 2 | 142 | 2 | 22099308 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24998570 | ||
| Pubmed | Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. | 1.66e-05 | 2 | 142 | 2 | 17846168 | |
| Pubmed | The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity. | 1.66e-05 | 2 | 142 | 2 | 28114273 | |
| Pubmed | IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. | 1.66e-05 | 2 | 142 | 2 | 20977743 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 10446341 | ||
| Pubmed | Preferential dimethylation of histone H4 lysine 20 by Suv4-20. | 1.66e-05 | 2 | 142 | 2 | 18296440 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22022429 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21206904 | ||
| Pubmed | Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2. | 1.66e-05 | 2 | 142 | 2 | 24396869 | |
| Pubmed | Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. | 1.66e-05 | 2 | 142 | 2 | 18180285 | |
| Pubmed | Crystal structure of the human SUV39H1 chromodomain and its recognition of histone H3K9me2/3. | 1.66e-05 | 2 | 142 | 2 | 23285239 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22951141 | ||
| Pubmed | A unique H3K4me2 profile marks tissue-specific gene regulation. | 1.66e-05 | 2 | 142 | 2 | 20841431 | |
| Pubmed | A novel route to product specificity in the Suv4-20 family of histone H4K20 methyltransferases. | 1.66e-05 | 2 | 142 | 2 | 24049080 | |
| Pubmed | Histone H4K20 tri-methylation at late-firing origins ensures timely heterochromatin replication. | 1.66e-05 | 2 | 142 | 2 | 28778956 | |
| Pubmed | SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR. | 1.66e-05 | 2 | 142 | 2 | 16409643 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 10051229 | ||
| Pubmed | SUV4-20 activity in the preimplantation mouse embryo controls timely replication. | 1.66e-05 | 2 | 142 | 2 | 27920088 | |
| Pubmed | Low frequency of H3.3 mutations and upregulated DAXX expression in MDS. | 1.66e-05 | 2 | 142 | 2 | 23660862 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 2.64e-05 | 377 | 142 | 9 | 38117590 | |
| Pubmed | 2.92e-05 | 15 | 142 | 3 | 28190768 | ||
| Pubmed | 3.59e-05 | 16 | 142 | 3 | 24788516 | ||
| Pubmed | Human Asf1 regulates the flow of S phase histones during replicational stress. | 3.59e-05 | 16 | 142 | 3 | 15664198 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX16 THOC7 NDUFS7 MARK1 NSD2 CECR2 PNISR LRCH1 CWC22 NKRF RRP1 NIFK SLTM MAP4K4 RPL7A | 3.88e-05 | 1082 | 142 | 15 | 38697112 |
| Pubmed | TBKBP1 H3-5 RGPD1 FAM98A H3-4 TFG H3-7 H3C15 GSR IQGAP1 H3C1 H3-3A RPL7A | 4.54e-05 | 844 | 142 | 13 | 25963833 | |
| Pubmed | 4.89e-05 | 49 | 142 | 4 | 34368113 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBKBP1 RHBDF1 NSD2 TMEM94 KMT5C OBSCN ADGRL1 RNF40 SFI1 ITGA3 ADCY7 TBC1D16 CLCN7 CAMSAP1 BAHCC1 | 4.92e-05 | 1105 | 142 | 15 | 35748872 |
| Pubmed | Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases. | 4.95e-05 | 3 | 142 | 2 | 33361816 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 18075750 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 31112471 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23720823 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23373701 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21274551 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 38749085 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 25023289 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23269674 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 26149421 | ||
| Pubmed | Molecular recognition of histone H3 by the WD40 protein WDR5. | 4.95e-05 | 3 | 142 | 2 | 16829960 | |
| Pubmed | Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex. | 4.95e-05 | 3 | 142 | 2 | 16829959 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 25722290 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21145462 | ||
| Pubmed | Cabin1 represses MEF2 transcriptional activity by association with a methyltransferase, SUV39H1. | 4.95e-05 | 3 | 142 | 2 | 17172641 | |
| Pubmed | Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes. | 4.95e-05 | 3 | 142 | 2 | 24595857 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 37150325 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28497778 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 22493426 | ||
| Pubmed | Structural insights into the globular tails of the human type v myosins Myo5a, Myo5b, And Myo5c. | 4.95e-05 | 3 | 142 | 2 | 24339992 | |
| Pubmed | Involvement of IQGAP family proteins in the regulation of mammalian cell cytokinesis. | 4.95e-05 | 3 | 142 | 2 | 25229330 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 31001581 | ||
| Pubmed | Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders. | 4.95e-05 | 3 | 142 | 2 | 24849541 | |
| Pubmed | The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription. | 4.95e-05 | 3 | 142 | 2 | 19481544 | |
| Pubmed | Structural insights into functional overlapping and differentiation among myosin V motors. | 4.95e-05 | 3 | 142 | 2 | 24097982 | |
| Interaction | NDC80 interactions | THOC7 IFT81 TTLL5 ANKRD26 MYO5C CEP135 ASPM DZIP3 ROCK1 MTCL1 FAM9C CAMSAP1 CSPP1 | 2.39e-07 | 312 | 138 | 13 | int:NDC80 |
| Interaction | H1-5 interactions | DENND2A H3-5 IQGAP2 NSD2 ANKRD26 DAXX RAD54L2 H3-4 H3-7 H3C15 ZSCAN20 H3C1 SVIL CEP83 H3-3A | 6.88e-07 | 463 | 138 | 15 | int:H1-5 |
| Interaction | INSYN1 interactions | 2.52e-06 | 169 | 138 | 9 | int:INSYN1 | |
| Interaction | H2BC5 interactions | H3-5 INCENP H3-4 H3-7 H3C15 IQGAP1 NCBP3 H3C1 SVIL ASPM H3-3A MAP4K4 | 3.03e-06 | 331 | 138 | 12 | int:H2BC5 |
| Interaction | H2AC14 interactions | 6.78e-06 | 144 | 138 | 8 | int:H2AC14 | |
| Interaction | LYN interactions | INCENP IQGAP2 NSD2 MARK3 MINK1 PSD3 ANKRD26 EXOC3 ADGRL1 ADAM22 IQGAP1 PTPN14 SH2D4A SVIL ROCK1 MAP4K4 RPL7A | 8.87e-06 | 720 | 138 | 17 | int:LYN |
| Interaction | RAB35 interactions | IQGAP2 MARK1 MARK3 MINK1 PSD3 ANKRD26 EXOC3 IQGAP1 PTPN14 CLCN7 H3-3A ROCK1 MAP4K4 NUP160 RPL7A | 9.30e-06 | 573 | 138 | 15 | int:RAB35 |
| Interaction | TPX2 interactions | 1.16e-05 | 204 | 138 | 9 | int:TPX2 | |
| Interaction | H2AC13 interactions | 1.26e-05 | 75 | 138 | 6 | int:H2AC13 | |
| Interaction | H3-5 interactions | 1.36e-05 | 114 | 138 | 7 | int:H3-5 | |
| Interaction | HMGN2 interactions | 2.28e-05 | 222 | 138 | 9 | int:HMGN2 | |
| Interaction | H2BC21 interactions | H3-5 INCENP NSD2 OBSCN DAXX RNF40 H3-4 H3-7 H3C15 ADHFE1 H3C1 SVIL DZIP3 H3-3A MAP4K4 BAHCC1 | 2.30e-05 | 696 | 138 | 16 | int:H2BC21 |
| Interaction | GAGE5 interactions | 2.81e-05 | 52 | 138 | 5 | int:GAGE5 | |
| Interaction | CEP63 interactions | 3.29e-05 | 179 | 138 | 8 | int:CEP63 | |
| Interaction | EPHA2 interactions | TPTE MARK1 TMEM94 MARK3 MINK1 PSD3 ANKRD26 EXOC3 ADGRL1 TBC1D22B ITGA3 EPB41L4A LRCH1 PTPN14 ROCK1 MAP4K4 | 3.41e-05 | 719 | 138 | 16 | int:EPHA2 |
| Interaction | SUV39H1 interactions | 3.93e-05 | 238 | 138 | 9 | int:SUV39H1 | |
| Interaction | ELK4 interactions | 4.07e-05 | 92 | 138 | 6 | int:ELK4 | |
| Interaction | H1-4 interactions | ASXL1 H3-5 NSD2 RAD54L2 H3-4 H3-7 H3C15 NKRF NIFK H3C1 SVIL CEP83 H3-3A THAP12 RPL7A | 4.47e-05 | 656 | 138 | 15 | int:H1-4 |
| Interaction | C11orf52 interactions | IQGAP2 MARK1 MARK3 MINK1 PSD3 ANKRD26 EXOC3 IQGAP1 PTPN14 MAP4K4 | 5.75e-05 | 311 | 138 | 10 | int:C11orf52 |
| Interaction | H2AC6 interactions | 6.50e-05 | 100 | 138 | 6 | int:H2AC6 | |
| Interaction | H2AC18 interactions | 7.26e-05 | 148 | 138 | 7 | int:H2AC18 | |
| Interaction | H2AC20 interactions | 7.28e-05 | 320 | 138 | 10 | int:H2AC20 | |
| Interaction | MSL3 interactions | 9.35e-05 | 35 | 138 | 4 | int:MSL3 | |
| Interaction | H2BC13 interactions | 1.01e-04 | 210 | 138 | 8 | int:H2BC13 | |
| Interaction | FLOT1 interactions | INCENP MARK3 MINK1 PSD3 ANKRD26 EXOC3 IQGAP1 PTPN14 H3C1 SVIL ROCK1 MAP4K4 | 1.06e-04 | 475 | 138 | 12 | int:FLOT1 |
| Interaction | IFI16 interactions | DHX16 INCENP NSD2 OBSCN RNF40 TFG NKRF RRP1 NCBP3 NIFK SVIL ASPM SLTM NUP160 RPL7A | 1.15e-04 | 714 | 138 | 15 | int:IFI16 |
| Interaction | NXF1 interactions | THOC7 RBM33 OBSCN RGPD1 WDR55 RNF40 FAM98A PNISR NXT2 ADAM22 NKRF IQGAP1 NCBP3 TBC1D16 BNIP2 SH2D4A H3C1 DZIP3 ROCK1 MTCL1 DAGLA WWC1 | 1.19e-04 | 1345 | 138 | 22 | int:NXF1 |
| Interaction | ARHGAP11A interactions | 1.36e-04 | 72 | 138 | 5 | int:ARHGAP11A | |
| Interaction | KDM5A interactions | 1.54e-04 | 74 | 138 | 5 | int:KDM5A | |
| Interaction | H2AC12 interactions | 1.63e-04 | 118 | 138 | 6 | int:H2AC12 | |
| Interaction | H2AC4 interactions | H3-5 EXOC3 DAXX RNF40 H3-4 H3-7 H3C15 RRP1 H3C1 SVIL DZIP3 H3-3A | 1.92e-04 | 506 | 138 | 12 | int:H2AC4 |
| Interaction | HPF1 interactions | 1.93e-04 | 42 | 138 | 4 | int:HPF1 | |
| Interaction | H1-1 interactions | H3-5 NSD2 DAXX H3-4 H3-7 H3C15 NKRF IQGAP1 NIFK H3C1 H3-3A RPL7A | 1.95e-04 | 507 | 138 | 12 | int:H1-1 |
| Interaction | PHF8 interactions | 1.99e-04 | 174 | 138 | 7 | int:PHF8 | |
| Interaction | RHOB interactions | IQGAP2 MARK3 MINK1 PSD3 ANKRD26 EXOC3 ADGRL1 ITGA3 IQGAP1 PTPN14 CLCN7 H3-3A ROCK1 MAP4K4 NUP160 RPL7A | 2.08e-04 | 840 | 138 | 16 | int:RHOB |
| Interaction | H2AC21 interactions | 2.13e-04 | 234 | 138 | 8 | int:H2AC21 | |
| Interaction | LZTS2 interactions | DHX16 TBKBP1 EAPP PHF19 EPB41L4A GEM IQGAP1 SH2D4A SUV39H1 CEP135 ASPM CSPP1 | 2.13e-04 | 512 | 138 | 12 | int:LZTS2 |
| Interaction | ZCCHC10 interactions | 2.26e-04 | 236 | 138 | 8 | int:ZCCHC10 | |
| Interaction | SETDB2 interactions | 2.38e-04 | 18 | 138 | 3 | int:SETDB2 | |
| Interaction | KIF23 interactions | DHX16 H3-5 INCENP MYO5B MINK1 NKRF IQGAP1 MYO5C NIFK H3C1 SVIL CEP135 ASPM H3-3A MTCL1 MAP4K4 THAP12 RPL7A | 2.41e-04 | 1031 | 138 | 18 | int:KIF23 |
| Interaction | H2BC9 interactions | H3-5 H3-4 H3-7 H3C15 ADCY7 H3C1 DGKK SVIL H3-3A RPL7A CCDC93 | 2.55e-04 | 446 | 138 | 11 | int:H2BC9 |
| Interaction | H2AC25 interactions | 2.80e-04 | 84 | 138 | 5 | int:H2AC25 | |
| Interaction | H2BC11 interactions | 2.99e-04 | 186 | 138 | 7 | int:H2BC11 | |
| Interaction | H2AC11 interactions | 3.15e-04 | 248 | 138 | 8 | int:H2AC11 | |
| Interaction | LOC102724334 interactions | 3.24e-04 | 134 | 138 | 6 | int:LOC102724334 | |
| Interaction | YWHAG interactions | MARK1 MARK3 MINK1 PSD3 ANKRD26 TBC1D22B FAM98A CWC22 GEM IQGAP1 PTPN14 H3C1 STARD9 SVIL MTCL1 CAMSAP1 MAP4K4 CSPP1 WWC1 PSD4 | 3.28e-04 | 1248 | 138 | 20 | int:YWHAG |
| Interaction | PIPSL interactions | 3.51e-04 | 252 | 138 | 8 | int:PIPSL | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 9.85e-07 | 34 | 97 | 5 | 487 | |
| GeneFamily | Histones | 3.76e-05 | 116 | 97 | 6 | 864 | |
| GeneFamily | Myosins, class V | 8.52e-05 | 3 | 97 | 2 | 1100 | |
| GeneFamily | Tubulin tyrosine ligase family | 2.49e-03 | 14 | 97 | 2 | 779 | |
| GeneFamily | StAR related lipid transfer domain containing | 2.86e-03 | 15 | 97 | 2 | 759 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.92e-03 | 181 | 97 | 5 | 694 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | MPO INCENP WDR55 FAM98A PNISR TFG NKRF CEP83 CEP135 ASPM SLTM DZIP3 ROCK1 MAP4K4 | 1.98e-06 | 469 | 136 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CECR2 ARX ANKRD26 EPB41L4A CWC22 H3C15 CEP83 CEP135 ASPM SLTM ROCK1 MTCL1 WWC1 | 1.95e-05 | 498 | 136 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.28e-05 | 311 | 136 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | MPO INCENP MYO5B ANKRD26 FAM98A EPB41L4A NKRF BRD8 CEP83 CEP135 ASPM SLTM ROCK1 | 3.87e-05 | 532 | 136 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MPO SLF1 INCENP NSD2 MARK3 CECR2 IFT81 ANKRD26 WDR55 PNISR CWC22 UBLCP1 GDNF NKRF CEP83 CEP135 ASPM SLTM DZIP3 ROCK1 CAMSAP1 CSPP1 BRWD1 | 5.15e-05 | 1459 | 136 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | MYO5B CECR2 ARX ANKRD26 EPB41L4A PNISR CWC22 H3C15 NKRF KLHL5 CEP83 CEP135 ASPM SLTM ROCK1 MTCL1 WWC1 BRWD1 | 6.19e-05 | 989 | 136 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SLF1 INCENP NSD2 MARK3 IFT81 ANKRD26 WDR55 PNISR UBLCP1 GDNF NKRF CEP83 CEP135 ASPM SLTM DZIP3 ROCK1 CAMSAP1 CSPP1 BRWD1 | 1.49e-04 | 1257 | 136 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | MPO ADAMTSL1 INCENP MYO5B CECR2 ARX ANKRD26 KMT2E CWC22 H3C15 NKRF CEP83 CEP135 ASPM SLTM ROCK1 WWC1 | 1.85e-04 | 983 | 136 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.91e-04 | 246 | 136 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.99e-04 | 186 | 136 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | MAFG CECR2 ARX RNF40 ADAM22 NKRF IQGAP1 BRD8 PTPN14 SUV39H1 DGKK ASPM SLTM ROCK1 MTCL1 MAP4K4 WWC1 | 2.11e-04 | 994 | 136 | 17 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.42e-04 | 192 | 136 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | Embryoid Body Cells-reprogram_OSKM - NLT_vs_Embryoid Body Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.42e-04 | 4 | 136 | 2 | PCBC_ratio_EB_from-OSKM - NLT_vs_EB_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | REC8 PHF19 CECR2 IFT81 TTLL5 ANKRD26 EPB41L4A UBLCP1 ADAM22 NKRF SUV39H1 DGKK CEP83 DZIP3 BRWD1 | 2.50e-04 | 820 | 136 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.44e-07 | 199 | 141 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 182 | 141 | 7 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 187 | 141 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 187 | 141 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 187 | 141 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.34e-06 | 188 | 141 | 7 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.69e-06 | 192 | 141 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 192 | 141 | 7 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-06 | 194 | 141 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 2.89e-06 | 194 | 141 | 7 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.19e-06 | 197 | 141 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-06 | 198 | 141 | 7 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 157 | 141 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-05 | 159 | 141 | 6 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 162 | 141 | 6 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.77e-05 | 171 | 141 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 176 | 141 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 2.15e-05 | 177 | 141 | 6 | eb87ea93e36a8f97442ec8515f658ee61932dc0f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 179 | 141 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-05 | 181 | 141 | 6 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-05 | 181 | 141 | 6 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 185 | 141 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 2.76e-05 | 185 | 141 | 6 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.84e-05 | 186 | 141 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.84e-05 | 186 | 141 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 187 | 141 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.93e-05 | 187 | 141 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 3.02e-05 | 188 | 141 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-05 | 188 | 141 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.20e-05 | 190 | 141 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.20e-05 | 190 | 141 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.30e-05 | 191 | 141 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 191 | 141 | 6 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 191 | 141 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 3.30e-05 | 191 | 141 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 191 | 141 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 3.30e-05 | 191 | 141 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 191 | 141 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.49e-05 | 193 | 141 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature|Fetal_brain / Sample Type, Dataset, Time_group, and Cell type. | 3.49e-05 | 193 | 141 | 6 | 1553c856f3b71c1b0a78ec8d59c7948144d9c5bb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 194 | 141 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-05 | 195 | 141 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 195 | 141 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.70e-05 | 195 | 141 | 6 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 3.81e-05 | 196 | 141 | 6 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.81e-05 | 196 | 141 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 3.81e-05 | 196 | 141 | 6 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.03e-05 | 198 | 141 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.19e-04 | 151 | 141 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 152 | 141 | 5 | 655d47efe0608d729801f1f01668e84c1bc0675f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 156 | 141 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.56e-04 | 160 | 141 | 5 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 163 | 141 | 5 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 165 | 141 | 5 | 3d14f37b8a9c0ddc1130e60a2e08556bad1fb855 | |
| ToppCell | Monocytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-04 | 165 | 141 | 5 | 83d06210a50073fbb7082eabd8298dd355c40416 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 165 | 141 | 5 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-04 | 166 | 141 | 5 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-04 | 166 | 141 | 5 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 167 | 141 | 5 | 7e61c5d2cdcfa6a2e3484b3994aec6b64ad75f07 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Control / Condition, Lineage and Cell class | 1.91e-04 | 167 | 141 | 5 | ab6029ba037b6a499da8758864c44e174cde5587 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 1.91e-04 | 167 | 141 | 5 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 169 | 141 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-04 | 172 | 141 | 5 | 9dca1542145d88559527db7e0f6ad150df59ca2d | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 2.25e-04 | 173 | 141 | 5 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.25e-04 | 173 | 141 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.25e-04 | 173 | 141 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-04 | 175 | 141 | 5 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-04 | 175 | 141 | 5 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 175 | 141 | 5 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 176 | 141 | 5 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 2.43e-04 | 176 | 141 | 5 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 176 | 141 | 5 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-04 | 176 | 141 | 5 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-04 | 177 | 141 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 178 | 141 | 5 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.57e-04 | 178 | 141 | 5 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 178 | 141 | 5 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 178 | 141 | 5 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 179 | 141 | 5 | 2c3abd646d2c8992e8ff76a824eab5beba8ba4c6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.63e-04 | 179 | 141 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.63e-04 | 179 | 141 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | ASK454-Epithelial-Ciliated|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.63e-04 | 179 | 141 | 5 | f21919ef9d3d984e2925ef3d24f89e20fe265dcd | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-04 | 179 | 141 | 5 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 179 | 141 | 5 | 6eb84fe9691ad40127b2d1f1c672428333c8fab4 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-04 | 179 | 141 | 5 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-04 | 180 | 141 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-04 | 180 | 141 | 5 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.70e-04 | 180 | 141 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-04 | 180 | 141 | 5 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-04 | 180 | 141 | 5 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-04 | 181 | 141 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 181 | 141 | 5 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.77e-04 | 181 | 141 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 181 | 141 | 5 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.84e-04 | 182 | 141 | 5 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.80e-06 | 196 | 141 | 9 | 7321_UP | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 3.80e-06 | 196 | 141 | 9 | 3331_UP | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 4.30e-06 | 199 | 141 | 9 | 3444_UP | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.00e-05 | 195 | 141 | 8 | 2223_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; HL60; HT_HG-U133A | 3.00e-05 | 195 | 141 | 8 | 3099_UP | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.00e-05 | 195 | 141 | 8 | 3191_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.12e-05 | 196 | 141 | 8 | 3183_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 3.12e-05 | 196 | 141 | 8 | 2249_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 7472_UP | |
| Drug | paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A | 3.35e-05 | 198 | 141 | 8 | 640_UP | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 5393_DN | |
| Drug | dexamethasone; Up 200; 1uM; MCF7; HG-U133A | 3.35e-05 | 198 | 141 | 8 | 123_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 6197_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 4133_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; HL60; HT_HG-U133A | 3.47e-05 | 199 | 141 | 8 | 1277_UP | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 1.20e-04 | 21 | 136 | 3 | OBA_2045083 | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 1.26e-04 | 4 | 136 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Parkinsonism | 2.88e-04 | 28 | 136 | 3 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 2.88e-04 | 28 | 136 | 3 | C0752097 | |
| Disease | Parkinsonism, Experimental | 2.88e-04 | 28 | 136 | 3 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 2.88e-04 | 28 | 136 | 3 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 2.88e-04 | 28 | 136 | 3 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 2.88e-04 | 28 | 136 | 3 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 2.88e-04 | 28 | 136 | 3 | C1868675 | |
| Disease | GLIOMA SUSCEPTIBILITY 1 | 3.13e-04 | 6 | 136 | 2 | C2750850 | |
| Disease | Parkinsonism, Juvenile | 3.55e-04 | 30 | 136 | 3 | C0752105 | |
| Disease | Parkinsonian Disorders | 3.55e-04 | 30 | 136 | 3 | C0242422 | |
| Disease | Amphetamine-Related Disorders | 4.07e-04 | 75 | 136 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 4.07e-04 | 75 | 136 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 4.07e-04 | 75 | 136 | 4 | C0236804 | |
| Disease | level of Phosphatidylcholine (16:0_22:4) in blood serum | 7.43e-04 | 9 | 136 | 2 | OBA_2045078 | |
| Disease | ovary epithelial cancer (is_implicated_in) | 1.13e-03 | 11 | 136 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | Diarrhea | 1.13e-03 | 11 | 136 | 2 | C0011991 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.35e-03 | 12 | 136 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 1.59e-03 | 13 | 136 | 2 | OBA_2045082 | |
| Disease | multiple sclerosis | 1.78e-03 | 594 | 136 | 9 | MONDO_0005301 | |
| Disease | 1-methylurate measurement | 1.85e-03 | 14 | 136 | 2 | EFO_0021173 | |
| Disease | immature platelet fraction | 1.95e-03 | 114 | 136 | 4 | EFO_0009187 | |
| Disease | body mass index, osteoarthritis | 2.00e-03 | 54 | 136 | 3 | EFO_0004340, MONDO_0005178 | |
| Disease | Dyskinesia, Medication-Induced | 2.13e-03 | 15 | 136 | 2 | C0751088 | |
| Disease | Autosomal recessive primary microcephaly | 2.13e-03 | 15 | 136 | 2 | cv:C3711387 | |
| Disease | Dyskinesia, Drug-Induced | 2.13e-03 | 15 | 136 | 2 | C0013386 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 2.13e-03 | 15 | 136 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | PR interval | 2.15e-03 | 495 | 136 | 8 | EFO_0004462 | |
| Disease | lysophosphatidylcholine measurement | 2.97e-03 | 62 | 136 | 3 | EFO_0010224 | |
| Disease | cystathionine measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0010474 | |
| Disease | Malignant Glioma | 4.18e-03 | 70 | 136 | 3 | C0555198 | |
| Disease | mixed gliomas | 4.18e-03 | 70 | 136 | 3 | C0259783 | |
| Disease | cataract | 4.19e-03 | 141 | 136 | 4 | MONDO_0005129 | |
| Disease | Autosomal Recessive Primary Microcephaly | 4.59e-03 | 22 | 136 | 2 | C3711387 | |
| Disease | sex interaction measurement, bilirubin measurement | 4.59e-03 | 22 | 136 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | Primary microcephaly | 4.59e-03 | 22 | 136 | 2 | C0431350 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AKYDIRVKNLKSRLR | 136 | Q13075 | |
| RRYKEKQRELARLQR | 1451 | Q9P281 | |
| AQRYKRKLREVQAEI | 501 | O75150 | |
| SLKDRERVKYRQELL | 451 | Q8NFR7 | |
| VIKETQERYRRLKRD | 111 | Q9H0E9 | |
| NKERTRNIVKYDLRT | 226 | O94910 | |
| ALYRLRAFEKDRQRK | 96 | Q969M2 | |
| RVIKEKRDAYVSRLN | 141 | P00390 | |
| KRSKRQLRRYPRNVE | 221 | Q9P0K1 | |
| LGLLVYRKRRAKREE | 601 | Q9NPY3 | |
| EVLRYKASENRKKRR | 216 | Q56P03 | |
| ERRYREASARKKIRL | 346 | Q8WXI4 | |
| DYTRLQKRLKDIQRR | 611 | Q9Y592 | |
| YTVKCIQIRRKLRIE | 211 | P51828 | |
| RRKRLEQQRKDYAAP | 136 | Q9Y4B4 | |
| KIREQLRRKEEQYRK | 811 | Q9UPS8 | |
| ERQELKYKRRVRDLA | 266 | O60231 | |
| RRELIKQEYLRRKQQ | 1336 | Q5T5Y3 | |
| RERTSLRERQLYKLL | 261 | Q9BXF3 | |
| AYLQEARLKRKLIRL | 221 | Q9UER7 | |
| REIREENKLYKRTAL | 3241 | Q8IZT6 | |
| LRTRARRNLYKKQES | 416 | Q8IXJ9 | |
| DQNKSAALRYRQRKR | 216 | Q9Y2D1 | |
| NQRRYRQRRKAELVK | 1491 | P46940 | |
| VKRYNRNRTLTQKLR | 146 | Q9BYG3 | |
| SRLVKREYLRVNVVK | 26 | O95072 | |
| ETRLYRLKIEEQKRL | 786 | Q96EV2 | |
| RRDTIQRLRQCKYDK | 496 | P25092 | |
| QRLRQCKYDKKRVIL | 501 | P25092 | |
| RILQYRLRKAEQKSL | 391 | Q9Y4B5 | |
| LRRDSKEKNERRLAY | 241 | P55040 | |
| VLLTRYDINKRDRKE | 51 | Q5JPF3 | |
| TVKRYNRRKAEELLL | 231 | D6REC4 | |
| KELLQRSYRKLEERV | 901 | Q5KSL6 | |
| EYKRQLLAERQKRIE | 386 | O95819 | |
| QLKQRRRTLKNRGYA | 51 | O15525 | |
| SQKNRRKKRRISYVQ | 61 | Q9NQS7 | |
| KVRLRLRYEEAKRRI | 301 | Q8IX03 | |
| LRYEEAKRRIANLKI | 306 | Q8IX03 | |
| LDKYQLRETKRRLQQ | 256 | Q86Y97 | |
| RDRTKRKIQRYVRKD | 46 | P48051 | |
| EIRRYQKSTELLIRK | 51 | P84243 | |
| KKRRITRYDAQLILE | 696 | Q4FZB7 | |
| RLILNFRKGYRRNDK | 236 | Q9HCG8 | |
| ARKVYIQTRRQRKLH | 866 | Q8N6G6 | |
| LVTRKDLARYRLGKR | 781 | P51798 | |
| EIRRYQKSTELLIRK | 51 | Q5TEC6 | |
| IRRYQKSTELLIRKL | 51 | Q6NXT2 | |
| LEKKLERERRRTQRY | 801 | Q6ZWH5 | |
| RARTRALYEAKRQKA | 1021 | P26006 | |
| AYKERRESIKQRLRS | 76 | P05164 | |
| IQRRKEKYRLELLEQ | 416 | Q1MSJ5 | |
| VYELQSKRLLLERRK | 1351 | Q92817 | |
| RRNRKRSIKYDSLLE | 166 | O96028 | |
| RQLRKRKQKYGNLRE | 171 | Q8NEA4 | |
| RRLRGCRNLYKKDLL | 36 | Q96JK2 | |
| RRYHSRRIQRDVIKK | 301 | Q53F19 | |
| KVSLLEYRKRQREAR | 1156 | Q8IZD2 | |
| SVLERDKLLRFRKQR | 426 | Q5VZ66 | |
| KSLRELNVRRNYLKV | 211 | Q9Y2L9 | |
| LRTALRYIQSLKRKE | 261 | Q99583 | |
| YDKILKNLSRNRRLV | 156 | P39905 | |
| EIRRYQKSTELLIRK | 51 | Q16695 | |
| EIRRYQKSTELLIRK | 51 | P68431 | |
| IYSLRNKDVKAAVRR | 296 | Q9NQN1 | |
| EQRRKDLSKLLAYIR | 396 | Q96PQ7 | |
| TEKERLARQRQLYKL | 746 | Q86Y13 | |
| RKRLKAYLRNTLTDQ | 701 | O43422 | |
| VFVRNREKRRALLYK | 7946 | Q5VST9 | |
| ERKYINIRKRLDQLG | 6 | Q66GS9 | |
| KEKLYKIRLLQARRN | 461 | Q567U6 | |
| LQRTNELKKRAYLAR | 106 | Q8WYA0 | |
| RINAIYEVRRGKKRV | 486 | Q9ULE3 | |
| RQLVDIRYSKDTRKQ | 341 | Q8IZJ3 | |
| YDRLIKESRRQKTRV | 711 | P12110 | |
| KYRLTNEVELRDKRI | 516 | Q5VVM6 | |
| RNLYIIGRKRKTLQL | 766 | Q9NSI6 | |
| LRKCYQQIDRRLRKN | 226 | Q12982 | |
| NLKELRERVLRGKYR | 261 | Q9P0L2 | |
| QNLKELRERVLRGKY | 256 | P27448 | |
| EGLLKRKQRRYRTTF | 321 | Q96QS3 | |
| KLRATKRRQRNLRTY | 166 | Q9Y4D2 | |
| ERENLKRLKCLRRYR | 251 | Q9H9L4 | |
| KIYIVLRRRRKRVNT | 211 | P14416 | |
| TQLKRQKRDYRISLK | 106 | Q8IZT9 | |
| IVYKLRRKSNFRLRG | 206 | Q6DWJ6 | |
| LDKVEQYRRREARKK | 26 | O60645 | |
| YLQVKKVRLREAERL | 11 | Q5T0J3 | |
| SNREYRKKRNRIRQE | 491 | Q9HCS5 | |
| NYLTTVQERKERKLR | 346 | P28476 | |
| LKRLNYDRKELERRR | 1081 | O75334 | |
| RLVELYRSNKRLKDA | 161 | P0DJD0 | |
| ALRIVAKYLKRAVRN | 286 | Q8IWW8 | |
| KRYADERRKQLVAAL | 771 | Q9P2E2 | |
| YKRKQLEEQRQSERL | 451 | Q8N4C8 | |
| KRRRALTRLYLDKAT | 31 | Q9NPJ8 | |
| LVYTLRNKEIKRALR | 286 | Q9GZK4 | |
| SKREVKRQKYRLSQL | 4416 | Q685J3 | |
| LAFVLERRRKKARLQ | 861 | A8K8P3 | |
| LEKQIEKRDKYSRRR | 186 | O95926 | |
| TERRKLTLQRKREEY | 231 | Q9NU19 | |
| KAERIARYKAERRRQ | 101 | O95425 | |
| AEKERIRIYKLNRRK | 181 | Q6ZQX7 | |
| RYLVVGRKRRKEDLL | 656 | O15226 | |
| IRLQRQRAILYKRLK | 61 | P62424 | |
| IANEYEVRRKLLIKR | 211 | Q8NCA5 | |
| AKDIRNQRIYRKLRK | 1401 | Q13576 | |
| NQRIYRKLRKAELAK | 1406 | Q13576 | |
| EIRRYQKSTELLIRK | 51 | Q71DI3 | |
| RRTYRKIIPKRNRNQ | 1041 | Q8NDX1 | |
| KLRRTRRYNVLSKNC | 6 | Q15678 | |
| NRTYRKRIDSFVKRQ | 381 | Q96CC6 | |
| LRYEQEKRNSLKRPR | 716 | Q9NWH9 | |
| EQVTRDRAVRKLRKY | 21 | P56182 | |
| DRAVRKLRKYIVART | 26 | P56182 | |
| ELYARQKKAIETLRR | 4251 | Q9P2P6 | |
| LYGILQLQRKIKRER | 191 | O75251 | |
| QKVDKATRDLLYRRT | 1421 | Q12769 | |
| NYLVQKAKQRRALRR | 116 | O43463 | |
| QYFKSLCREIKQRRR | 1121 | Q13023 | |
| ERERRKRSQKELLNY | 51 | Q9NSQ0 | |
| EKLIRRRVSENKRRY | 216 | P56180 | |
| SRLDRYKIARQLTEK | 36 | A6PVC2 | |
| RTLEQCRYRVKNLLR | 371 | P17040 | |
| EIRVRVRYQKRQKLQ | 1331 | Q12767 | |
| QVKYLRRELIELRNK | 101 | Q92734 | |
| CRILQYRLRKAERKR | 406 | Q5TF21 | |
| REALRLQKRKEYSEI | 451 | Q8TBP0 | |
| HEFQQQKRRVYRRKR | 381 | Q5T6S3 | |
| RRSLAKQAREDYKRL | 246 | Q9H788 | |
| LRRELIYKRNERIGK | 296 | Q86V40 | |
| RIRKNRQEYDALAKV | 111 | Q6I9Y2 | |
| QGYNKTLLRLRLRKE | 586 | Q9P0L9 | |
| DEDIQRSYTLRRKRK | 301 | Q9BQI6 | |
| LSRYKDTINKIRDLR | 56 | Q13464 | |
| QLRAVVVDDYRRRKK | 326 | Q9H6Y2 | |
| REENLLKISRRVKEY | 111 | Q8WVY7 | |
| YSRRIKIESNRARVK | 576 | Q8TF01 | |
| ENATLRRRLKVYEIK | 61 | A7MCY6 | |
| KRLAKRLYQLDRFKR | 586 | Q9NYI0 | |
| RVQKLVRRYKLAIAT | 6 | Q9H1B5 | |
| LYERKLLSLEVRKRR | 541 | Q6EMB2 | |
| GKRYKRRLNLDIILS | 431 | Q9UK12 | |
| RLIKRYVLKAQVDRE | 786 | Q9HCX4 | |
| ATKRRILKERIYRLT | 686 | P20592 | |
| RYRVLVKKRELANTD | 706 | Q9ULV0 | |
| LQRKKFLRERRAALI | 771 | Q9NQX4 |